NVO » Topics » Sustainability issues update

This excerpt taken from the NVO 6-K filed Jan 29, 2009.

Sustainability issues update

‘Unite to Change Diabetes’ Leadership Forum in Moscow
The international Forum ‘Unite to Change Diabetes’ in Moscow, hosted by the Russian Diabetes Federation and in partnership with Novo Nordisk, brought together over 300 participants, including medical professionals, policymakers, patient groups and media from all regions of the Russian Federation and CIS countries. Its aim was to examine the current condition of diabetes in Russia and how well the healthcare system is meeting the growing challenge of diabetes. Key points for discussion were primary prevention of type 2 diabetes, improving the effectiveness of diagnosis and effective treatment to minimise or delay the onset of complications.

In the spring of 2009, Novo Nordisk will publish a briefing book, presenting the situation of diabetes care in Russia today, achievements and challenges, along with conclusions and recommendations generated by the Forum. Former Secretary-General of the United Nations Kofi Annan addressed the Forum, which was the second in a series of international diabetes leadership forums, initiated by Novo Nordisk.

Free insulin and access to diabetes care for children in the world’s poorest countries
In December, Novo Nordisk announced a five-year plan to provide diabetes care, including free insulin, to 10,000 children in some of the world’s poorest countries. The programme, ‘Changing the Future for Children with Diabetes’, begins in 2009 with an initial roll-out in Uganda, Tanzania, Guinea-Conakry and the Democratic Republic of Congo. It is estimated that some 38,000 African children aged 0–14 have type 1 diabetes.

A series of satellite centres will be set up around existing hospitals and clinics to offer free insulin and treatment as well as diagnosis, registration, patient education and healthcare training. The programme builds on an approach begun in 2006, which referred children with type 1 diabetes to a Novo Nordisk-funded diabetes clinic in Dar es Salaam, Tanzania. At the clinic, mortality among children has decreased dramatically. A diabetes nurse is assigned to work with children and their families, which has also reduced emergency admissions to the clinic. The programme builds on partnerships with the World Diabetes Foundation and local partners such as national diabetes associations and Ministries of Health.

 

This excerpt taken from the NVO 6-K filed May 6, 2008.

Sustainability issues update

Novo Nordisk calls for joint effort to prevent diabetes
Novo Nordisk actively supports the implementation of the UN Resolution on Diabetes globally and organises a series of national forums to bring diabetes on the political agenda. In April,

Stock Exchange Announcement no 24 / 2008
Financial statement for the period 1 January 2008 to 31 March 2008
Page 8 of 18

Novo Nordisk A/S

Investor Relations
Novo Allé
2880 Bagsværd
Denmark
Telephone:
+45 4444 8888
Telefax:
+45 4443 6633
Internet:
novonordisk.com
CVR number:
24256790
 

Novo Nordisk supported a meeting with around 300 diabetes experts, policy-makers, patient representatives, industry and media to discuss how to stop the epidemic growth in diabetes in Denmark. Experts predict a twofold increase in the number of people with diabetes over the next 20 years if no action is taken. This would entail a 50% increase in the socio-economic burden from diabetes. The delegates concluded that more can and should be done to prevent diabetes and its serious complications. Prevention needs to be a priority in city planning, schools and at workplaces. Measures to detect diabetes early and ensure cohesive and patient-centred care should be the standard in all regions. This was backed by the Danish Minister of Health and health policy representatives from the Danish parliament, regions and counties who vouched for the political commitment to take appropriate action now.

In Italy a similar event led to a broad coalition for a new diabetes coordination agency, a screening campaign and support for data collection to the Novo Nordisk-led Changing Diabetes® Barometer. The Changing Diabetes® Barometer measures the current state of diabetes and pinpoints areas in need for improvement. The tool enables healthcare providers, governments and patient associations to measure progress and set priorities for national diabetes action plans.

 

This excerpt taken from the NVO 6-K filed Oct 30, 2006.
Sustainability issues update
At the annual meeting of the European Association for the Study of Diabetes (EASD) held in Copenhagen in September, Novo Nordisk launched its largest ever diabetes awareness initiative, targeted at policymakers, media, healthcare professionals, people with diabetes and the general public. One of the initiatives includes a ‘Changing Diabetes Bus’, which is a showroom containing interactive communications about diabetes and the importance of prevention, early detection and good control. A diabetes specialist and a nurse are on board to answer questions and measure visitors' blood glucose levels. Part of its mission is to support the International Diabetes Federation's campaign, Unite for Diabetes. The Changing Diabetes Bus aims at reaching one billion people over the next year when the bus will travel across five continents to end at the UN building in New York on World Diabetes Day, 14 November 2007.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki